Pappas James C

Director Pappas James C buys 505,555 shares of IVFH at $0.30; holds 8.80M shares (8.8% larger). Cluster pattern with 3 other insiders in 14 days.

Director James C Pappas purchased 505,555 shares at $0.30 on 2026-01-06, increasing his holdings from 8.29M to 8.80M shares. This buy occurs within a cluster of 3 other insider purchases over the preceding 14 days, signaling synchronized management accumulation at current levels. Pappas's prior 4 trades at IVFH show strong timing: each generated positive 90-day returns (24.4%, 10.8%, 10.4%, and 11.6% respectively), establishing a demonstrated pattern of entry discipline at this ticker. The stock has declined 83.4% from its 52-week high of $2.35 but has recovered 11.4% in the past 30 days; the fundamentals remain weak with trailing net income of -$1.7M against revenue of $16.4M. The synchronized cluster buying by multiple insiders, combined with Pappas's historical accuracy on IVFH entries, suggests management views the current depressed valuation as attractive, though deteriorating annual revenue growth (-0.1%) and ongoing losses present material execution risk.

Director Pappas buys 17,000 shares ($573,000) across 2 transactions, raising stake to 194.2K shares amid -20.3% 90-day decline.

Pappas James C, a director, made 2 separate purchases totaling 17,000 shares for $573,000.00, executed at $33.76 on 2026-01-02 and $33.30 on 2026-01-05, with a blended average price of $33.71. The stock is currently trading at $33.87, near the transaction price, but down 20.3% over 90 days and -21.3% from its 52-week high of $43.04. The company is unprofitable, with net income of $-4.0M in its latest quarter and full-year negative results, despite $7.8B in quarterly revenue and modest +2.6% annual growth. Pappas's cross-ticker track record shows 5 prior open-market buys with a 100.00% 90-day win rate and average 90-day return of +13.2%, suggesting consistent execution across his transaction history, though this pattern is not ticker-specific and UNFI itself is operating at a loss. The 9.6% increase in his stake signals continued confidence, but investors should weigh this against the company's unprofitability and recent price momentum."

Director James C Pappas buys 156,250 shares of IVFH at $1.60 ($250,000); 3-insider cluster pattern in 14 days

Pappas James C, a director at Innovative Food Holdings Inc (IVFH), purchased 156,250 shares (156.2K shares) at $1.60 on 2024-12-09 for $250,000.00 ($250.0K), increasing his holdings to 8,290,675 shares (8.29M shares). His prior three purchases at IVFH over the past 13 months all delivered positive 90-day returns (10.8%, 14.4%, 10.4%, 11.6%, and 0.5% returns across the transactions), establishing a track record of well-timed entry points at this ticker. This current transaction is part of a cluster buy pattern—2 other insiders purchased within the past 14 days—signaling synchronized conviction among board and management. However, context demands caution: IVFH reported a negative full-year net income in its most recent fiscal period despite the latest quarterly net income of $1,334,830.00 ($1.3M), and annual revenue contracted 9.8% year-over-year, pointing to structural business headwinds that offset the positive entry-timing history.

Director Pappas James C bought 1,250,000 shares of IVFH at $1.20 on 2024-07-17, raising stake to 1,618,492 shares (+339.2%).

Director Pappas James C executed a substantial open-market purchase of 1,250,000 shares at $1.20 on 2024-07-17, totaling $1,500,000.00, raising his holdings from 368,492 shares to 1,618,492 shares — a 339.2% increase. His prior two purchases at IVFH (in November 2023) both produced positive 30-day and 90-day returns, establishing a pattern of well-timed entry points at this ticker. The current stock price is $1.22, only 1.6% above his transaction price, while the 90-day return from this filing date stands at +29.8%, indicating the position has appreciated meaningfully since purchase. However, the company's fundamentals remain challenging: annual revenue declined 9.8% year-over-year, the company was unprofitable over its most recent full fiscal year, and quarterly revenue stands at $15,730,113.00 with net income of $1,425,874.00 — a single-quarter swing to profitability that requires scrutiny as to its sustainability. The magnitude of this position increase combined with the insider's demonstrated timing acumen at this specific ticker warrants monitoring of subsequent insider activity and earnings announcements to confirm whether this accumulation represents sustained conviction or an isolated opportunistic purchase.